Sort
11,323 grants matching “glioblastoma”
Cytochrome C Oxidase in Malignant Gliomas
$294,868Corinne E. Griguer · University Of Alabama At Birmingham · R01 · FY2014 · CA
The role of HEF1 protein in division and invasion of metastatic breast cancer
$294,868Elena Nikolaevna Pugacheva · West Virginia University · R01 · FY2012 · CA
The role of HEF1 protein in division and invasion of metastatic breast cancer
$294,868Elena Nikolaevna Pugacheva · West Virginia University · R01 · FY2011 · CA
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
$294,868Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2014 · CA
Development of Anticancer 1,2-Bis(sulfonyl)hydrazines
$294,589Alan Clayton Sartorelli · Yale University · R01 · FY2008 · CA
FAK and Pky2 in Determination of Glioblastoma Phenotype
$294,554Mayo Clinic Arizona · R01 · FY2005 · CA
Development of Anticancer 1,2-Bis(sulfonyl)hydrazines
$294,515Alan Clayton Sartorelli · Yale University · R01 · FY2007 · CA
Predicting Tumor Heterogeneity Evolution After Therapy in Patient-derived Ex Vivo Glioblastoma Organoids
$294,336Aleksander Skardal · Ohio State University · R21 · FY2019 · CA
Neoantigen immunotherapy in brain tumors using anti-CD27 to deplete regulatory T cells selectively
$294,300John H Sampson · Duke University · P50 · FY2022 · CA
Clinical Development of 4-Hydroperoxyifosfamide
$294,271Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2006 · CA
MDA-7/IL-24: Therapy of Malignant Glioma
$294,179Paul Dent · Virginia Commonwealth University · P01 · FY2008 · CA
MECHANISMS OF CELLULAR RADIOSENSITIVITY
$294,139Johns Hopkins University · P01 · FY2001 · CA
MECHANISMS OF CELLULAR RADIOSENSITIVITY
$294,139Johns Hopkins University · P01 · FY2002 · CA
Predictive Imaging Biomarkers for GBM Therapeutic Response and Recurrence
$294,035Thomas L. Chenevert · University Of Michigan At Ann Arbor · P01 · FY2017 · CA
The Role of Lyn in Glioma Progression and Migration
$294,008Candece L Gladson · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · CA
A Novel Target for CAR T Cell Therapy Using Precision Oncology Approaches
$293,897Anthony Cooper · Javelin Oncology, Inc. · R43 · FY2019 · CA
Computational prediction of tumor progression in brachytherapy
$293,871Chieh Hou · Brown University · P20 · FY2025 · GM
Tumor exosomes as agents of genetic change
$293,820Xandra Owens Breakefield · Massachusetts General Hospital · R01 · FY2010 · CA
Tumor exosomes as agents of genetic change
$293,682Xandra Owens Breakefield · Massachusetts General Hospital · R01 · FY2009 · CA
KDM1A inhibitors as novel therapeutics for glioblastoma
$293,563Gangadhara R Sareddy · University Of Texas Hlth Science Center · R01 · FY2020 · NS
KDM1A inhibitors as novel therapeutics for glioblastoma
$293,563Gangadhara R Sareddy · University Of Texas Hlth Science Center · R01 · FY2023 · NS
KDM1A inhibitors as novel therapeutics for glioblastoma
$293,563Gangadhara R Sareddy · University Of Texas Hlth Science Center · R01 · FY2019 · NS
KDM1A inhibitors as novel therapeutics for glioblastoma
$293,563Gangadhara R Sareddy · University Of Texas Hlth Science Center · R01 · FY2022 · NS
Dendritic Cell-Brain Tumor Stem Cell Fusion Vaccines
$293,550Gregory E Plautz · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · CA
Dendritic Cell-Brain Tumor Stem Cell Fusion Vaccines
$293,550Gregory E Plautz · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · CA